Navigation Links
Third Wave's revenues rebound

Madison, Wis. - At their annual shareholder's meeting, Third Wave Technologies announced increased revenues for the first quarter 2006 and several promising ventures for the rest of the year, but company officials still were unable to say when they would begin to show profit.

Kevin Conroy, president and chief executive officer of Third Wave, told as......

Full article >>> all Street last year, and it takes a while to regain market confidence," he said.

In addition to altered expectations, the company also has had to deal with legal issues over its Invader technology, a product line that includes tests for genetic mutations associated with immune response and drug metabolism. In October of 2005, Third Wave filed patent lawsuits against multiple companies, a......

Full article >>> market at $80 million.

Lai said getting repeat customers and partnerships like these will be a key to Third Wave's progress. "The molecular diagnostics field is very competitive, and once you get a base of users through the field, they tend to be very sticky, they adopt your technology, and become a great space," Lai said. "Third Wave is showing signs of traction in selling their diagnos......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 06/13/06


Related biology technology :

1. Third Wave files countersuit vs. Digene in patent case
2. Third Wave reports net loss of $18.9M for 2006
3. Stratagene to pay Third Wave $10.75M in patent case
4. Third Wave responds to Digene patent lawsuit
5. Third Wave seeks approval of Cystic Fibrosis test
6. Third Wave Technologies to raise $14.9M through private debt
7. Third Wave reports $5.2M third quarter loss
8. Third Wave reports another loss, stronger sales
9. Napier joins board of Third Wave Technologies
10. Third Wave reports clinical growth, continued loss
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2017)... Massachusetts and NEW YORK , ... Biologics License Application accepted by the FDA for avelumab  ... the disease has metastasized   ... Germany , in the US and ... the US Food and Drug Administration (FDA) has accepted for ...
(Date:2/27/2017)... Michigan (PRWEB) , ... February ... ... international award-winning high-pressure pasteurized cold-pressed fruit and vegetable drink brand is now ... with Michigan-based Vegesentials USA, LLC to manufacture and distribute the Vegesentials line ...
(Date:2/27/2017)... 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... February 24, 2017 a total of 10,672,750 common share purchase ... common share. Proceeds from the exercise of these warrants totalled ... ... are grateful for this expression of confidence by our warrant ...
(Date:2/27/2017)... NEW YORK , February 27, 2017 ... up by Stock-Callers.com for evaluation today, and they are: ... ARWR), Pacific Biosciences of California Inc. (NASDAQ: PACB), and ... to an article on ETF Trends, market observers are ... Congress and administration could enact reforms to free cash ...
Breaking Biology Technology:
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
(Date:1/24/2017)... 2017  It sounds simple and harmless—an electronic ... vital signs and alerts parents on their smart ... level drops. But pediatric experts argue that such ... no evidence of medical benefits, especially to healthy ... to parents of healthy babies, promising peace of ...
Breaking Biology News(10 mins):